Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Nina Prokoph
The Targetable Kinase PIM1 Drives ALK Inhibitor Resistance in High-Risk Neuroblastoma Independent of MYCN Status
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
Treatment Options for Paediatric Anaplastic Large Cell Lymphoma (ALCL): Current Standard and Beyond
Cancers
Cancer Research
Oncology
Related publications
The Aurora Kinase Inhibitor CCT137690 Downregulates MYCN and Sensitizes MYCN-Amplified Neuroblastoma in Vivo
Molecular Cancer Therapeutics
Cancer Research
Oncology
Impact of MYCN Status on Response of High-Risk Neuroblastoma to Neoadjuvant Chemotherapy
Journal of Pediatric Surgery
Medicine
Child Health
Surgery
Pediatrics
Perinatology
The ALK Inhibitor PF-06463922 Is Effective as a Single Agent in Neuroblastoma Driven by Expression of ALK and MYCN
DMM Disease Models and Mechanisms
Immunology
Molecular Biology
Biochemistry
Microbiology
Neuroscience
Medicine
Genetics
MYCN Controls an Alternative RNA Splicing Program in High-Risk Metastatic Neuroblastoma
Cancer Letters
Cancer Research
Oncology
PP2A Inhibitor PME-1 Drives Kinase Inhibitor Resistance in Glioma Cells
Cancer Research
Cancer Research
Oncology
Aberrant Activation of ALK Kinase by a Novel Truncated Form ALK Protein in Neuroblastoma
Oncogene
Cancer Research
Genetics
Molecular Biology
Inhibition of Autophagy Potentiates the Efficacy of Gli Inhibitor GANT-61 in MYCN-amplified Neuroblastoma Cells
BMC Cancer
Cancer Research
Oncology
Genetics
Aurora B Kinase Is a Potent and Selective Target in MYCN-driven Neuroblastoma
Oncotarget
Oncology
Ataxia-Telangiectasia Mutated (ATM) Silencing Promotes Neuroblastoma Progression Through a MYCN Independent Mechanism
Oncotarget
Oncology
